{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:54:29Z","timestamp":1761519269611,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funding for this study has been generously provided by a Herbert family philanthropic donation, including PhD scholarship support for G.B. Funding has also been provided by the GRC Genomics Lymphoma Project (GLP) fund.","award":["LG01"],"award-info":[{"award-number":["LG01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Recent studies show an association of microRNA (miRNA) polymorphisms (miRSNPs) in different cancer types, including non-Hodgkin lymphoma (NHL). The identification of miRSNPs that are associated with NHL susceptibility may provide biomarkers for early diagnosis and prognosis for patients who may not respond well to current treatment options, including the immunochemotherapy drug combination that includes rituximab, cyclophosphamide, doxorubicin, vincristine and prednisome (R-CHOP). We developed a panel of miRSNPs for genotyping while using multiplex PCR and chip-based mass spectrometry analysis in an Australian NHL case-control population (300 cases, 140 controls). Statistical association with NHL susceptibility was performed while using Chi-square (\u03c72) and logistic regression analysis. We identified three SNPs in MIR143 that are to be significantly associated with reduced risk of NHL: rs3733846 (odds ratio (OR) [95% confidence interval (CI)] = 0.54 [0.33\u20130.86], p = 0.010), rs41291957 (OR [95% CI] = 0.61 [0.39\u20130.94], p = 0.024), and rs17723799 (OR [95% CI] = 0.43 [0.26\u20130.71], p = 0.0009). One SNP, rs17723799, remained significant after correction for multiple testing (p = 0.015). Subsequently, we investigated an association between the rs17723799 genotype and phenotype by measuring target gene Hexokinase 2 (HKII) expression in cancer cell lines and controls. Our study is the first to report a correlation between miRSNPs in MIR143 and a reduced risk of NHL in Caucasians, and it is supported by significant SNPs in high linkage disequilibrium (LD) in a large European NHL genome wide association study (GWAS) meta-analysis.<\/jats:p>","DOI":"10.3390\/genes10030185","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:41:03Z","timestamp":1551267663000},"page":"185","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations"],"prefix":"10.3390","volume":"10","author":[{"given":"Gabrielle","family":"Bradshaw","sequence":"first","affiliation":[{"name":"Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7735-8110","authenticated-orcid":false,"given":"Larisa M.","family":"Haupt","sequence":"additional","affiliation":[{"name":"Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunise M.","family":"Aquino","sequence":"additional","affiliation":[{"name":"Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney A.","family":"Lea","sequence":"additional","affiliation":[{"name":"Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-1498","authenticated-orcid":false,"given":"Heidi G.","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-5475","authenticated-orcid":false,"given":"Lyn R.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Genomics Research Centre, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4001, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.transci.2013.07.014","article-title":"Epidemiology of Non-Hodgkin Lymphoma","volume":"49","author":"Skrabek","year":"2013","journal-title":"Transfus. Apheresis Sci."},{"key":"ref_2","unstructured":"(2018, November 15). Cancer Facts & Figures 2018. Available online: https:\/\/www.cancer.org\/."},{"key":"ref_3","unstructured":"(2018, November 15). Lymphoma Coalition Europe. Available online: https:\/\/www.lymphomacoalition.org\/europe."},{"key":"ref_4","unstructured":"Australian Institute of Health and Welfare 2017 (2018, September 23). Cancer in Australia 2017 Cancer Series No. 101. Cat. No. CAN 100. Canberra: AIHW, Available online: www.aihw.gov.au."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12291-015-0511-3","article-title":"Serum Lactate Dehydrogenase in Non-Hodgkin\u2019s Lymphoma: A Prognostic Indicator","volume":"31","author":"Yadav","year":"2016","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2003","journal-title":"J. Cell. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_9","first-page":"83","article-title":"MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions","volume":"3","author":"Shukla","year":"2011","journal-title":"Mol. Cell. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2012.08.016","article-title":"SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer","volume":"137","author":"Salzman","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.molcel.2004.12.002","article-title":"Transcription and Processing of Human microRNA Precursors","volume":"16","author":"Cullen","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1160\/TH11-12-0836","article-title":"Regulation of microRNA biogenesis and function","volume":"107","author":"Treiber","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.gde.2018.01.001","article-title":"Emerging roles of microRNAs in cancer","volume":"48","author":"Vannini","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_14","first-page":"69","article-title":"In silico analysis of polymorphisms in microRNAs that target genes affecting aerobic glycolysis","volume":"4","author":"Suresh","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"D181","DOI":"10.1093\/nar\/gkx1035","article-title":"MSDD: A manually curated database of experimentally supported associations among miRNAs, SNPs and human diseases","volume":"46","author":"Yue","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/humu.21641","article-title":"Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis","volume":"33","author":"Gong","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zheng, B., Xi, Z., Liu, R., Yin, W., Sui, Z., Ren, B., Miller, H., Gong, Q., and Liu, C. (2018). The Function of MicroRNAs in B-Cell Development, Lymphoma, and Their Potential in Clinical Practice. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00936"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2014.08.006","article-title":"MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies","volume":"93","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bradshaw, G., Sutherland, H., Haupt, L., and Griffiths, L. (2016). Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma. Genes, 7.","DOI":"10.3390\/genes7120130"},{"key":"ref_20","first-page":"787","article-title":"The Warburg effect: A balance of flux analysis","volume":"11","author":"Vaitheesvaran","year":"2015","journal-title":"Metab. Off. J. Metab. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gu, J.J., Singh, A., Xue, K., Mavis, C., Barth, M., Yanamadala, V., Lenz, P., Grau, M., Lenz, G., and Czucman, M.S. (2017). Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development. Oncotarget, 4020\u20134033.","DOI":"10.18632\/oncotarget.23425"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1568026618666180523111351","article-title":"Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer","volume":"18","author":"Akins","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/1541-7786.MCR-09-0234","article-title":"Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis","volume":"7","author":"Palmieri","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/2159-8290.CD-13-0565","article-title":"Glycolysis Back in the Limelight: Systemic Targeting of HK2 Blocks Tumor Growth","volume":"3","author":"Ros","year":"2013","journal-title":"Cancer Discov."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mushtaq, M., Darekar, S., Klein, G., and Kashuba, E. (2015). Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136142"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41598-018-19182-8","article-title":"Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL","volume":"8","author":"Bhalla","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10863-015-9637-5","article-title":"Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells","volume":"48","author":"Kwiatkowska","year":"2016","journal-title":"J. Bioenergy Biomembr."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chacon-Cortes, D., Smith, R.A., Haupt, L.M., Lea, R.A., Youl, P.H., and Griffiths, L.R. (2015). Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility. BMC Med. Genet., 16.","DOI":"10.1186\/s12881-015-0248-0"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.gene.2015.10.019","article-title":"Association of the microRNA-Single Nucleotide Polymorphism rs2910164 in miR146a with sporadic breast cancer susceptibility: A case control study","volume":"576","author":"Upadhyaya","year":"2016","journal-title":"Gene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1007\/s11033-011-1408-8","article-title":"Comparison of genomic DNA extraction techniques from whole blood samples: A time, cost and quality evaluation study","volume":"39","author":"Haupt","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_34","unstructured":"Team, R. (2015). RStudio: Integrated Development for R, RStudio, Inc.. Available online: http:\/\/www.rstudio.com."},{"key":"ref_35","first-page":"263","article-title":"Haploview: Analysis and visualization of LD and haplotype maps","volume":"21","author":"Fry","year":"2004","journal-title":"Bioinformatics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s13277-014-2957-y","article-title":"A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma","volume":"36","author":"Li","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ng.3105","article-title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma","volume":"46","author":"Cerhan","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/gtmb.2015.0271","article-title":"A Single-Nucleotide Polymorphism of miR-196a2T>C rs11614913 Is Associated with Hepatocellular Carcinoma in the Chinese Population","volume":"20","author":"Li","year":"2016","journal-title":"Genet. Test Mol. Biomark."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canep.2016.09.007","article-title":"MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study","volume":"45","author":"Thapa","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2147\/OTT.S154211","article-title":"rs11614913 polymorphism in miRNA-196a2 and cancer risk: An updated meta-analysis","volume":"11","author":"Liu","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.humimm.2013.04.019","article-title":"Association between polymorphisms in the promoter region of miR-143\/145 and risk of colorectal cancer","volume":"74","author":"Li","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wu, J., Huang, Q., Meng, D., Huang, M., Li, C., and Qin, T. (2016). A Functional rs353293 Polymorphism in the Promoter of miR-143\/145 Is Associated with a Reduced Risk of Bladder Cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159115"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"23227","DOI":"10.1074\/jbc.M112.373084","article-title":"MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene","volume":"287","author":"Fang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/onc.2012.100","article-title":"miR-143 regulates hexokinase 2 expression in cancer cells","volume":"32","author":"Peschiaroli","year":"2012","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/emboj.2012.45","article-title":"A novel miR-155\/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells","volume":"31","author":"Jiang","year":"2012","journal-title":"Embo J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biopha.2018.10.037","article-title":"Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis","volume":"109","author":"Zeinali","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.3760\/cma.j.issn.0366-6999.20122931","article-title":"Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer","volume":"126","author":"Zeng","year":"2013","journal-title":"Chin. Med. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/cas.12280","article-title":"Tumor-suppressive microRNA-143\/145 cluster targets hexokinase-2 in renal cell carcinoma","volume":"104","author":"Yoshino","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_49","first-page":"983","article-title":"Histone deacetylase inhibitor prevents cell growth in Burkitt\u2019s lymphoma by regulating PI3K\/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101","volume":"93","author":"Robaina","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3892\/or.2014.3078","article-title":"Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells","volume":"31","author":"Shen","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/bio.2015.0032","article-title":"A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreserv. Biobank."},{"key":"ref_52","unstructured":"Bcndoye (2018, November 09). Comparison of LDH Activity in Normal and Cancerous Cell Metabolism. Available online: https:\/\/commons.wikimedia.org\/wiki\/File:LDH_activity-_normal_vs_canceous_cells.png."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/3\/185\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:35:13Z","timestamp":1760186113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/3\/185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["genes10030185"],"URL":"https:\/\/doi.org\/10.3390\/genes10030185","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}